In addition, the high expression of ERGIC3 was positively correlated with the infiltration of B cells, macrophage, myeloid dendritic cells, CD4+ T and other immune cells, suggesting that ERGIC3 may affect the prognosis of liver cancer patients by raising the abundance of infiltrating immune cells. This evidence concerns the gene CD4 and liver cancer.